Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide.

MLA

Toyosaki, Masako, et al. “Primary CNS Post-Transplant Lymphoproliferative Disorder Following Haploidentical HSCT Using Post-Transplant High-Dose Cyclophosphamide.” Blood Cell Therapy, vol. 2, no. 1, Oct. 2018, pp. 1–4. EBSCOhost, https://doi.org/10.31547/bct-2018-004.

APA

Toyosaki, M., Onizuka, M., Amaki, J., Shiraiwa, S., Aoyama, Y., Machida, S., Kawai, H., Murayama, H., Ogiya, D., Matsui, K., Kawakami, S., Harada, K., Kondo, Y., Hirabayashi, K., Nakamura, N., Ogawa, Y., Kawada, H., & Ando, K. (2018). Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide. Blood Cell Therapy, 2(1), 1–4. https://doi.org/10.31547/bct-2018-004

Chicago

Toyosaki, Masako, Makoto Onizuka, Jun Amaki, Sawako Shiraiwa, Yasuyuki Aoyama, Shinichiro Machida, Hidetsugu Kawai, et al. 2018. “Primary CNS Post-Transplant Lymphoproliferative Disorder Following Haploidentical HSCT Using Post-Transplant High-Dose Cyclophosphamide.” Blood Cell Therapy 2 (1): 1–4. doi:10.31547/bct-2018-004.